MBLX Metabolix Inc

Yield10 Bioscience to Present at the 20th Annual Rodman and Renshaw Global Investment Conference in New York City September 4-6, 2018

Yield10 Bioscience to Present at the 20th Annual Rodman and Renshaw Global Investment Conference in New York City September 4-6, 2018

WOBURN, Mass., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN), a company focused on developing new technologies to achieve step-change improvements in crop yield to enhance global food security, today announced that it will be featured as a presenting company at the 20th Annual Rodman & Renshaw Global Investment Conference, sponsored by H.C. Wainwright & Co. LLC. The conference is being held September 4-6, 2018 at the St. Regis Hotel in New York City. 

Kristi Snell, Ph.D., Chief Science Officer of Yield10, will provide an overview of the Company’s business in a presentation scheduled on Wednesday, September 5, 2018 at 11:40 am EDT. Management will also be meeting with members of the investment community during one-on-one meetings.

 
Event: 20th Annual Rodman & Renshaw Global Investment Conference
Date: Wednesday, September 5, 2018
Time: 11:40 am (EDT)
Location: Maisonnette I (Lower Level) St. Regis Hotel in New York City
 

A live audio webcast and copy of the presentation can be accessed through the following link  or through the “Investors” section of the Company's website at .  The webcast replay will remain available for 90 days following the live presentation. 

About Yield10 Bioscience

Yield10 Bioscience, Inc. is focused on developing new technologies to achieve step-change improvements in crop yield to enhance global food security. Yield10 has an extensive track record of innovation based around optimizing the flow of carbon in living systems.  Yield10 is leveraging its technology platforms and unique knowledge base to design precise alterations to gene activity and the flow of carbon in plants to produce higher yields with lower inputs of land, water or fertilizer. Yield10 is advancing several yield traits it has developed in crops such as Camelina, canola, soybean and rice. Yield10 is headquartered in Woburn, MA and has an Oilseeds Center of Excellence in Saskatoon, Canada. 

For more information about the company, please visit .

(YTEN-G)

Contacts: 

Yield10 Bioscience:

Lynne H. Brum, (617) 682-4693,

Investor Relations: 

Amato and Partners, LLC

Media Inquiries:

Eric Fischgrund

Fischtank Marketing and PR

 

EN
28/08/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Metabolix Inc

 PRESS RELEASE

Yield10 Bioscience Announces Second Quarter 2024 Financial Results

Yield10 Bioscience Announces Second Quarter 2024 Financial Results WOBURN, Mass., Aug. 14, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) ("Yield10" or the "Company"), an agricultural bioscience company, today reported financial results for the second quarter ended June 30, 2024. "We continue to work closely with the Nufarm team to finalize the asset purchase agreement announced in July,” said Oliver Peoples, Ph.D., President and Chief Executive Officer of Yield10. “We believe that the transition of our Omega-3 Camelina program to Nufarm is in the best interest of our sh...

 PRESS RELEASE

Yield10 Bioscience Grants Nufarm a Commercial License to Omega-3 Asset...

Yield10 Bioscience Grants Nufarm a Commercial License to Omega-3 Assets for Producing Oil in Camelina, and Yield10 and Nufarm sign a Memorandum of Understanding for Sale of Assets - Nufarm to pay up to USD $5 million in consideration for the license-The parties will negotiate the sale of essentially all of Yield10’s assets to Nufarm WOBURN, Mass. and WEST SACRAMENTO, Calif., July 17, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (OTC:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company has signed a Memorandum of Understanding (“MOU”...

 PRESS RELEASE

Rothamsted Research Grants Yield10 Bioscience an Exclusive, Global Com...

Rothamsted Research Grants Yield10 Bioscience an Exclusive, Global Commercial License to Advanced Technology for Producing Omega-3 Products in Camelina Engineered Camelina is intended to enable the land-based production of omega-3 oils used in aquafeed, petfood and human nutrition WOBURN, Mass. and HARPENDEN, United Kingdom, June 17, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (OTC:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that U.K.-based Rothamsted Research Limited (“Rothamsted”) has granted to the Company an exclusive global, commerc...

 PRESS RELEASE

Yield10 Bioscience Announces Addition of Camelina to INTERLINE® Herbic...

Yield10 Bioscience Announces Addition of Camelina to INTERLINE® Herbicide Label - EPA approved an amendment to the label of INTERLINE herbicideto include Camelina -The supplemental label now allows application of INTERLINE for over-the-top weed control in Camelina WOBURN, Mass., May 23, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (OTC:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that UPL Ltd. (“UPL”) has received U.S. Environmental Protection Agency (“EPA”) approval to of INTERLINE® Herbicide to include the oilseed Camelina sativa (“Came...

 PRESS RELEASE

Yield10 Bioscience Announces First Quarter 2024 Financial Results

Yield10 Bioscience Announces First Quarter 2024 Financial Results -Earns $1 million in milestone payments from Vision Bioenergy Oilseeds WOBURN, Mass., May 15, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) ("Yield10" or the "Company"), an agricultural bioscience company, today reported financial results for the first quarter ended March 31, 2024. "In the first quarter of 2024, we made the strategic decision to focus our resources on the commercialization of Camelina products targeting the aquafeed and nutritional markets for omega-3 fatty acids," said Oliver Peoples, ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch